Compare EVO & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | MLKN |
|---|---|---|
| Founded | 1993 | 1905 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2021 | N/A |
| Metric | EVO | MLKN |
|---|---|---|
| Price | $3.31 | $15.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 99.6K | ★ 1.2M |
| Earning Date | 11-05-2025 | 12-17-2025 |
| Dividend Yield | N/A | ★ 4.74% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $887,396,457.00 | ★ $3,764,100,000.00 |
| Revenue This Year | N/A | $5.40 |
| Revenue Next Year | $10.78 | $3.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.37 |
| 52 Week Low | $2.84 | $13.77 |
| 52 Week High | $5.10 | $25.96 |
| Indicator | EVO | MLKN |
|---|---|---|
| Relative Strength Index (RSI) | 49.54 | 53.47 |
| Support Level | $2.89 | $13.77 |
| Resistance Level | $3.24 | $16.19 |
| Average True Range (ATR) | 0.09 | 0.55 |
| MACD | 0.04 | 0.29 |
| Stochastic Oscillator | 95.65 | 81.96 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.